Clinical Trial Update: Study Assessing PTI-428 Safety, Tolerability, Pharmacokinetics and Effect in Subjects With Cystic Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial update for PTI-428 (proteostasis therapeutics) assessing safety, tolerability, pharmacokinetics, and effect in cystic fibrosis patients has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• PTI-428

Snippet

Sponsor: Proteostasis Therapeutics, Inc. | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED